Cargando…

The ratio of serum LL-37 levels to blood leucocyte count correlates with COVID-19 severity

Beneficial effects of vitamin D on COVID-19 progression have been discussed in several studies. Vitamin D stimulates the expression of the antimicrobial peptide LL-37, and evidence shows that LL-37 can antagonize SARS-CoV-2. Therefore, we investigated the association between LL-37 and vitamin D seru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keutmann, Matthias, Hermes, Gabriele, Meinberger, Denise, Roth, Annika, Stemler, Jannik, Cornely, Oliver A., Klatt, Andreas R., Streichert, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175165/ https://www.ncbi.nlm.nih.gov/pubmed/35676519 http://dx.doi.org/10.1038/s41598-022-13260-8

Ejemplares similares

Analysis of IgM, IgA, and IgG isotype antibodies Directed against SARS-CoV-2 spike glycoprotein and ORF8 in the course of COVID-19
por: Meinberger, Denise, et al.
Publicado: (2021)

Modified CLEC3A-Derived Antimicrobial Peptides Lead to Enhanced Antimicrobial Activity against Drug-Resistant Bacteria
por: Meinberger, Denise, et al.
Publicado: (2023)

Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
por: Stemler, Jannik, et al.
Publicado: (2022)

The Differential Leucocyte Count
por: Hefferman, L. W.
Publicado: (1923)

Value of the Leucocyte Count
Publicado: (1907)

Serum LL‐37 and inflammatory cytokines levels in psoriasis
por: Lao, Juanfeng, et al.
Publicado: (2023)

The Leucocyte Count in Weil's Disease
por: Kennedy, C. Cotton
Publicado: (1958)

The Significance of Arneth's Leucocyte Count
por: Knapp, H. H. G.
Publicado: (1915)

Leucocyte Counts in Surgical Prognosis
por: McDonald, Stuart
Publicado: (1931)

Generation of Monoclonal Antibodies Specific for Native LL37 and Citrullinated LL37 That Discriminate the Two LL37 Forms in the Skin and Circulation of Cutaneous/Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients
por: Lande, Roberto, et al.
Publicado: (2020)

The Role of Cathelicidin LL-37 in Cancer Development
por: Piktel, Ewelina, et al.
Publicado: (2015)

Significance of LL-37 on Immunomodulation and Disease Outcome
por: Yang, Binbin, et al.
Publicado: (2020)

Regulation of LL-37 in Bone and Periodontium Regeneration
por: Chinipardaz, Zahra, et al.
Publicado: (2022)

The Total and Differential Leucocyte Count in Brucellosis
por: Mathur, T. N.
Publicado: (1955)

Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
por: Tokajuk, Joanna, et al.
Publicado: (2022)

LL-37 Triggers Antimicrobial Activity in Human Platelets
por: Sánchez-Peña, Francisco Javier, et al.
Publicado: (2023)

Serum Levels of LL-37 and Inflammatory Cytokines in Plaque and Guttate Psoriasis
por: Hwang, Young Ji, et al.
Publicado: (2014)

CXCR2 specific endocytosis of immunomodulatory peptide LL-37 in human monocytes and formation of LL-37 positive large vesicles in differentiated monoosteophils
por: Zhang, Zhifang, et al.
Publicado: (2019)

Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma
por: Stemler, Jannik, et al.
Publicado: (2020)

Eosinophilia: Blood Films and the Differential Leucocyte Count
Publicado: (1907)

Prognostic Significance of Leucocytic Count in Bubonic Plague
por: Wagle, P. M., et al.
Publicado: (1947)

A Possible Pitfall in Making Leucocyte Counts
por: Dastidar, S. K. Ghosh
Publicado: (1930)

Constancy of the Day-To-Day Leucocyte Blood Count
por: Harvey, W. F., et al.
Publicado: (1934)

Role of LL-37 in thrombotic complications in patients with COVID-19
por: Duan, Zilei, et al.
Publicado: (2022)

Impaired tolerance to the autoantigen LL-37 in acute coronary syndrome
por: Chernomordik, Fernando, et al.
Publicado: (2023)

Differential Leucocyte Counts Which May Assist Diagnosis
Publicado: (1907)

Differential Leucocyte Counts Which May Assist Diagnosis
Publicado: (1907)

Influence of the Leucocyte Count in the Decision for or against Immediate Operation
por: Van Duyn, E. S.
Publicado: (1904)

EQUAL Score Scedosporiosis/Lomentosporiosis 2021: a European Confederation of Medical Mycology (ECMM) tool to quantify guideline adherence
por: Stemler, Jannik, et al.
Publicado: (2021)

Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections
por: Majewski, Karol, et al.
Publicado: (2018)

Expression and significance of serum vitamin D and LL-37 levels in infants with bacterial pneumonia
por: Zhao, Shaojie, et al.
Publicado: (2022)

Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia
por: Podaza, Enrique, et al.
Publicado: (2020)

LL-37 at the local site of streptococcal skin and soft-tissue infections
por: Thulin, Pontus, et al.
Publicado: (2007)

Evaluation of the Ability of LL-37 to Neutralise LPS In Vitro and Ex Vivo
por: Scott, Aaron, et al.
Publicado: (2011)

Vesicular LL-37 Contributes to Inflammation of the Lesional Skin of Palmoplantar Pustulosis
por: Murakami, Masamoto, et al.
Publicado: (2014)

LL-37 Induces Polymerization and Bundling of Actin and Affects Actin Structure
por: Sol, Asaf, et al.
Publicado: (2012)

Antimicrobial peptide LL-37 participates in the transcriptional regulation of melanoma cells
por: Muñoz, Mindy, et al.
Publicado: (2016)

Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms
por: Kang, Jason, et al.
Publicado: (2019)

Pulmonary defense and the human cathelicidin hCAP-18/LL-37
por: Fahy, R. J., et al.
Publicado: (2005)

Synergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37
por: Sadeghi, Somayeh, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_montggf9kg64a7kpc6lig0dolu